Ask a doctor about a prescription for TRACRIUM 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION
Package Leaflet: Information for the User
Tracrium 10 mg/ml Solution for Injection and Infusion
Atracurium, Besylate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Package Leaflet
Tracrium belongs to a group of medicines called muscle relaxants.
It is used to relax muscles during many surgical operations, as well as in Intensive Care Units. It may also be used to help insert a tube into the trachea if mechanical assistance is required to breathe.
Do not use Tracrium
Warnings and Precautions
Tell your doctor if you or a member of your family has had an unusual reaction to an anaesthetic (e.g. an unexpectedly long action), or if you or any member of your family has a warning card indicating that this has happened in the past.
During the administration of Tracrium, there is a possibility that histamine (a substance involved in allergies) may be released in susceptible patients. Caution should be exercised when administering Tracrium to patients with a history suggesting increased sensitivity to the effects of histamine.
Before starting treatment with Tracrium, tell your doctor if you have or have had:
Tell your doctor:
Using Tracrium with other medicines
Tell your doctor or pharmacist if you are using or have recently used other medicines, including those obtained without a prescription.
Tracrium may interact with other medicines. It is important that you tell your doctor before receiving this medicine if you know you are taking any of the following medicines (consult your doctor if you are in doubt):
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Driving and using machines
It may be dangerous to drive or operate machinery immediately after being operated on. Your doctor will tell you how long you should wait before you can drive and use machinery.
Tracrium should only be administered under carefully controlled conditions, under the supervision of an experienced doctor familiar with the use and action of muscle relaxants.
Your doctor will decide on the dose and duration of treatment with Tracrium that he considers suitable for your operation.
Use in Children
Tracrium is not recommended for use in children under 1 month of age.
The dose of Tracrium is determined based on body weight expressed in kilograms, the amount and duration of muscle relaxation desired, the expected response of the patient to the medicine, and the way the medicine is to be administered. During muscle relaxation, your doctor will monitor neuromuscular function (nerves and muscles) to confirm that the dose being administered is correct.
If you use more Tracrium than you should
The effects of Tracrium are carefully controlled throughout the surgical procedure, and in the unlikely event that too much medicine is administered, corrective actions will be taken immediately.
Like all medicines, Tracrium can cause side effects, although not everybody gets them.
The side effects that may appear during or after the operation are as follows (those marked with the symbol # are attributed to the release of histamine):
Common side effects (may affect between 1 and 10 in every 100 people)
Uncommon side effects (may affect between 1 and 10 in every 1,000 people)
If these effects appear, they will not last long and will be controlled by your doctor during the procedure.
Rare side effects (may affect between 1 and 10 in every 10,000 people)
Very rare side effects (may affect up to 1 in every 10,000 people)
Side effects with frequency not known
If you think any of the side effects you are experiencing are serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Store in a refrigerator (between 2°C and 8°C). Do not freeze.
Store in the original packaging to protect from light.
Any remaining Tracrium in opened ampoules should be discarded.
Do not use this medicine after the expiry date which is stated on the packaging. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Tracrium
Appearance and packaging of the product
Tracrium is a solution for injection, presented in 2.5 ml or 5 ml ampoules.
Each pack contains 5 ampoules.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Aspen Pharma Trading Limited
3016 Lake Drive,
Citywest Business Campus,
Dublin 24, Ireland
Tel: +34 952 010 137
Manufacturer
Aspen Bad Oldesloe GmbH,
Industriestrasse 32-36,
23843 Bad Oldesloe,
Germany
Or
GlaxoSmithKline Manufacturing S.p.A.
Strada Provinciale Asolana, 90
43056 San Polo di Torrile (Parma)
Italy
Or
Aspen Pharma Ireland Limited
3016 Lake Drive, Citywest Business Campus
Dublin 24, Ireland
Local Representative:
ASPEN PHARMACARE ESPAÑA, S.L.
Avenida Diagonal, 512,
Planta Interior 1, Oficina 4,
Barcelona, 08006, Spain
This information is intended only for healthcare professionals:
Tracrium is compatible with the following infusion solutions for the times shown below:
Infusion Solution | Stability Period |
Intravenous infusion of sodium chloride British Pharmacopoeia (BP) (0.9% w/v) | 24 hours |
Intravenous infusion of glucose (5% w/v) BP | 8 hours |
Ringer's injection USP | 8 hours |
Intravenous infusion of sodium chloride (0.18% w/v) and glucose (4% w/v) BP | 8 hours |
Intravenous infusion of compound sodium lactate BP (Hartmann's solution) | 4 hours |
When diluted in these infusion solutions to achieve concentrations of atracurium besylate of 0.5 mg/ml and above, the resulting solutions will be stable at temperatures up to 25°C, under daylight, and for the periods shown.
Date of last revision of this leaflet:September 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for TRACRIUM 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION – subject to medical assessment and local rules.